DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study

ObjectiveTo evaluate the efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with hepatic arterial infusion chemotherapy (HAIC), donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma (uHCC).MethodsThis multicenter retrospective...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Yuanjin Ma, Jian Long, Shangbo Shi, Xinyi Fang, Ruidong Wang, Feng Xiong, Hong Ren, Wei Li, Xuexian Zhang
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2026-05-01
Seri Bilgileri:	Frontiers in Immunology
Konular:	camrelizumab donafenib drug-eluting bead transarterial chemoembolization hepatic arterial infusion chemotherapy hepatocellular carcinoma
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1779170/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!